Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2025 Earnings Call Transcript November 3, 2025
Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $2.66, expectations were $1.12.
Operator: Thank you for standing by, and welcome to the Krystal Biotech Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now like to hand the conference over to your host, Stephane Paquette, Vice President of Corporate Development. Please...
